UniProtKB/Swiss-Prot Q9H156: Variant p.Ser9Ile

SLIT and NTRK-like protein 2
Gene: SLITRK2
Feedback?

Variant information Variant position:

9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Isoleucine (I) at position 9 (S9I, p.Ser9Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a patient with a neurodevelopmental disorder; uncertain significance; does not affect surface expression; does not affect function in synaptogenesis. Any additional useful information about the variant.

Sequence information Variant position:

9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

845 The length of the canonical sequence.
Location on the sequence:

MLSGVWFL S VLTVAGILQTESRKTAKDIC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MLSGVWFLSVLTVAGILQTESRKTAKDIC

Mouse                         MLSGVWFLSVLTVAGILQTESRKTAKDIC

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Signal peptide	1 – 21

Literature citations
SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice.
El Chehadeh S.; Han K.A.; Kim D.; Jang G.; Bakhtiari S.; Lim D.; Kim H.Y.; Kim J.; Kim H.; Wynn J.; Chung W.K.; Vitiello G.; Cutcutache I.; Page M.; Gecz J.; Harper K.; Han A.R.; Kim H.M.; Wessels M.; Bayat A.; Jaen A.F.; Selicorni A.; Maitz S.; de Brouwer A.P.M.; Silfhout A.V.; Armstrong M.; Symonds J.; Kuery S.; Isidor B.; Cogne B.; Nizon M.; Feger C.; Muller J.; Torti E.; Grange D.K.; Willems M.; Kruer M.C.; Ko J.; Piton A.; Um J.W.;
Nat. Commun. 13:4112-4112(2022)
Cited for: INVOLVEMENT IN XLID111; VARIANTS XLID111 SER-74; LYS-210; ALA-312; ARG-374; CYS-426; 461-GLU--LEU-845 DEL AND MET-511; CHARACTERIZATION OF VARIANTS XLID111 SER-74; LYS-210; ALA-312; ARG-374; CYS-426; 461-GLU--LEU-845 DEL AND MET-511; VARIANTS ILE-9; GLU-15; ILE-201; ALA-311; GLN-484; ASP-555 AND CYS-792; CHARACTERIZATION OF VARIANTS ILE-9; GLU-15; ILE-201; ALA-311; ASN-323; GLN-484; ASP-555; ILE-589 AND CYS-792; FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH NTRK2;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.